• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Cerus Corp (CERS)

Common Shares
Sell: $1.29|Buy: $1.33|Change: 0.02 (-1.52%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Address

1220 Concord Avenue
Suite 600
Concord
CA
USA
94520

Telephone

+1 925 2886137

Website

https://www.cerus.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Cerus Corp First Quarter Earnings Conference Call for 20262026-05-01T16:30:00
Cerus Corp First Quarter Earnings Results for 20262026-05-01T00:00:00
Cerus Corp Annual Report for 20252026-02-26T00:00:00
Cerus Corp Fourth Quarter Earnings Conference Call for 20252026-02-20T16:30:00
Cerus Corp Fourth Quarter Earnings Results for 20252026-02-20T00:00:00
Cerus Corp Third Quarter Earnings Conference Call for 20252025-10-30T16:30:00
Cerus Corp Third Quarter Earnings Results for 20252025-10-30T00:00:00
Cerus Corp Second Quarter Earnings Conference Call for 20252025-08-01T16:30:00
Cerus Corp Second Quarter Earnings Results for 20252025-08-01T00:00:00
Cerus Corp Annual General Meeting for 20252025-06-05T08:00:00
Cerus Corp First Quarter Earnings Conference Call for 20252025-05-01T16:30:00
Cerus Corp First Quarter Earnings Result for 20252025-05-01T00:00:00

Previous key dates

NameKey Date
Cerus Corp First Quarter Earnings Conference Call for 20252025-05-01T16:30:00
Cerus Corp First Quarter Earnings Result for 20252025-05-01T00:00:00
TD Cowen 45th Annual Health Care Conference2025-03-05T11:10:00
Cerus Corp Annual Report for 20242025-02-26T00:00:00
Cerus Corp Fourth Quarter Earnings Conference Call for 20242025-02-20T16:30:00
Cerus Corp Fourth Quarter Earnings Result for 20242025-02-20T00:00:00
Stifel 2024 Healthcare Conference2024-11-18T16:10:00
Cerus Corp Third Quarter Earnings Conference Call for 20242024-10-30T16:30:00
Cerus Corp Third Quarter Earnings Result for 20242024-10-30T00:00:00
Cerus Corporation Provides Updates on INTERCEPT Red Blood Cell Programs2024-10-16T17:00:00
Cerus Corp Second Quarter Earnings Conference Call for 20242024-08-01T16:30:00
Cerus Corp Second Quarter Earnings Result for 20242024-08-01T00:00:00
Cerus Corp Annual General Meeting for 20242024-06-05T08:00:00
Cerus Corporation to Participate in 21st Annual Craig-Hallum Institutional Investor Conference2024-05-29T00:00:00
Cerus Corp First Quarter Earnings Conference Call for 20242024-05-02T16:30:00
Cerus Corp First Quarter Earnings Result for 20242024-05-02T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.